Viral and antibody dynamics of acute infection with SARS-CoV-2 omicron variant (B.1.1.529): a prospective cohort study from Shenzhen, China

抗体 病毒学 免疫学 病毒载量 医学 队列 前瞻性队列研究 严重急性呼吸综合征冠状病毒2型(SARS-CoV-2) 生物 疾病 2019年冠状病毒病(COVID-19) 病毒 内科学 传染病(医学专业)
作者
Yang Yang,Liping Guo,Jing Yuan,Zhixiang Xu,Yuchen Gu,Jiaqi Zhang,Guanming Yuan,Jinhu Liang,Hongzhou Lu,Yingxia Liu
出处
期刊:The Lancet microbe [Elsevier BV]
卷期号:4 (8): e632-e641 被引量:12
标识
DOI:10.1016/s2666-5247(23)00139-8
摘要

Elucidating viral dynamics within the host is important for designing public health measures against SARS-CoV-2, particularly during the early stages of infection when transmission potential rapidly increases. We aimed to analyse the viral and antibody dynamics of the omicron variant in relation to symptom onset or laboratory confirmation and replication dynamics throughout the infection course.In this prospective cohort study, patients with laboratory-confirmed SARS-CoV-2 infection who were admitted to Shenzhen Third People's Hospital (Shenzhen, China) between Jan 11, 2020, and April 24, 2022, were screened for eligibility. We included immunocompetent individuals with acute SARS-CoV-2 infection without antiviral agents targeting SARS-CoV-2. Serial nasopharyngeal swabs and plasma samples were analysed for viral RNAs and specific IgG antibodies of SARS-CoV-2. The comparative viral and antibody kinetics in association with symptom onset or laboratory confirmation and replication dynamics throughout the infection course were calculated by the locally estimated scatterplot smoothing curve fitting polynomial regression. The associations between viral and antibody dynamics and vaccination, age, sex, disease severity, and underlying health conditions were analysed using the Mann-Whitney U test and the Gehan-Breslow-Wilcoxon method.15 406 serial nasopharyngeal swabs and 2324 plasma samples were taken from 2043 individuals with acute SARS-CoV-2 infection (n=217 prototype [A.1] and D614G [B.1] variant [wild-type]; n=105 delta variant [B.1.617.2]; n=1721 omicron variant [B.1.1.529]) and were included for the analyses. The mean Ct value of omicron variant on the first day post symptom onset (dpo; defined as the first day post laboratory confirmation in asymptomatic participants) was 22·65 (95% CI 22·05-23·26). Peak viral load was reached with a mean Ct value of 17·63 (17·47-17·79) at a mean of 3·19 dpo (95% CI 3·09-3·28), and viral clearance (Ct values ≥35) was reached at a mean of 13·50 dpo (95% CI 13·32-13·67). Omicron variant showed faster viral replication and clearance than wild-type SARS-CoV-2 and delta variant, and the viral load at the first dpo and the peak viral load was lower than delta variant but higher than wild-type SARS-CoV-2. Age, sex, disease severity, and underlying health conditions were associated with the viral dynamics of omicron variant, with faster viral clearance found in young (aged 0-14 years), male, and asymptomatic participants, and those without underlying health conditions. Replication dynamics thoughout the infection course showed that peak viral load was reached at a mean of 5·06 dpo (4·76-5·36) and viral clearance took a mean of 14·27 days (13·6-14·93) for omicron variant. SARS-CoV-2-specific IgG increased earlier and faster to significantly higher concentrations in breakthrough infection than naive infection with omicron variant, despite long intervals (≥7 months) between the last dose of vaccination and infection.Our data provide a comprehensive overview of the longitudinal viral and antibody dynamics of omicron variant in people with acute SARS-CoV-2 infection, with important implications for public health strategies, including population screening, antiviral treatment, isolation periods, and vaccination.National Natural Science Foundation of China and Emergency Key Program of Guangzhou Laboratory.For the Chinese translation of the abstract see Supplementary Materials section.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
英俊的铭应助科研通管家采纳,获得10
刚刚
mmyhn应助科研通管家采纳,获得20
刚刚
李爱国应助科研通管家采纳,获得10
刚刚
失眠醉易应助科研通管家采纳,获得20
刚刚
刚刚
科研通AI5应助科研通管家采纳,获得10
刚刚
Ava应助科研通管家采纳,获得10
刚刚
科研通AI5应助科研通管家采纳,获得10
刚刚
Owen应助科研通管家采纳,获得10
刚刚
科研通AI5应助科研通管家采纳,获得10
刚刚
小蘑菇应助科研通管家采纳,获得10
刚刚
共享精神应助科研通管家采纳,获得10
刚刚
共享精神应助科研通管家采纳,获得10
刚刚
在水一方应助科研通管家采纳,获得10
刚刚
星辰大海应助科研通管家采纳,获得10
1秒前
orixero应助科研通管家采纳,获得10
1秒前
无花果应助科研通管家采纳,获得10
1秒前
Lucas应助科研通管家采纳,获得10
1秒前
桐桐应助科研通管家采纳,获得10
1秒前
顾矜应助科研通管家采纳,获得10
1秒前
1秒前
1234完成签到,获得积分10
1秒前
蓝天发布了新的文献求助10
1秒前
Alanni完成签到 ,获得积分10
2秒前
机灵柚子应助林甜甜很甜采纳,获得20
4秒前
4秒前
5秒前
ZiyuanLi完成签到,获得积分10
5秒前
CipherSage应助义气绿柳采纳,获得10
5秒前
临床医学研究中心给临床医学研究中心的求助进行了留言
5秒前
YIBYYDS发布了新的文献求助10
6秒前
小刘完成签到,获得积分10
6秒前
合适的若菱完成签到,获得积分10
7秒前
花h完成签到 ,获得积分10
7秒前
可爱的函函应助halashao采纳,获得10
8秒前
我是老大应助彩色南霜采纳,获得10
9秒前
zheng華发布了新的文献求助10
9秒前
10秒前
坚强似狮完成签到,获得积分10
11秒前
蓝天完成签到,获得积分10
13秒前
高分求助中
Technologies supporting mass customization of apparel: A pilot project 600
Разработка метода ускоренного контроля качества электрохромных устройств 500
Chinesen in Europa – Europäer in China: Journalisten, Spione, Studenten 500
Arthur Ewert: A Life for the Comintern 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi // Kurt Werner Radtke 500
Two Years in Peking 1965-1966: Book 1: Living and Teaching in Mao's China // Reginald Hunt 500
Epigenetic Drug Discovery 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3817682
求助须知:如何正确求助?哪些是违规求助? 3360954
关于积分的说明 10410402
捐赠科研通 3079042
什么是DOI,文献DOI怎么找? 1690956
邀请新用户注册赠送积分活动 814272
科研通“疑难数据库(出版商)”最低求助积分说明 768068